Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease

Rationale & Objective: The objective of the study was to estimate the prevalence of hypertension in patients with proteinuric kidney disease and evaluate blood pressure (BP) control. Study Design: Retrospective cohort study. Setting & Participants: Data from adults and children with proteinu...

Full description

Bibliographic Details
Main Authors: Donald J. Weaver, Jr., Anne Waldo, Gia J. Oh, Elaine S. Kamil, Matthew Elliott, Sharon Adler, Anne Pesenson, Meg M. Modes, Patrick Gipson, Richard A. Lafayette, David T. Selewski, Samara E. Attalla, Richard Eikstadt, Jonathan P. Troost, Debbie S. Gipson, Susan F. Massengill
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:Kidney Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059520300017
id doaj-899d8103430c4959aaf1e74a4511fe59
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Donald J. Weaver, Jr.
Anne Waldo
Gia J. Oh
Elaine S. Kamil
Matthew Elliott
Sharon Adler
Anne Pesenson
Meg M. Modes
Patrick Gipson
Richard A. Lafayette
David T. Selewski
Samara E. Attalla
Richard Eikstadt
Jonathan P. Troost
Debbie S. Gipson
Susan F. Massengill
spellingShingle Donald J. Weaver, Jr.
Anne Waldo
Gia J. Oh
Elaine S. Kamil
Matthew Elliott
Sharon Adler
Anne Pesenson
Meg M. Modes
Patrick Gipson
Richard A. Lafayette
David T. Selewski
Samara E. Attalla
Richard Eikstadt
Jonathan P. Troost
Debbie S. Gipson
Susan F. Massengill
Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
Kidney Medicine
author_facet Donald J. Weaver, Jr.
Anne Waldo
Gia J. Oh
Elaine S. Kamil
Matthew Elliott
Sharon Adler
Anne Pesenson
Meg M. Modes
Patrick Gipson
Richard A. Lafayette
David T. Selewski
Samara E. Attalla
Richard Eikstadt
Jonathan P. Troost
Debbie S. Gipson
Susan F. Massengill
author_sort Donald J. Weaver, Jr.
title Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
title_short Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
title_full Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
title_fullStr Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
title_full_unstemmed Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
title_sort time to initiation of antihypertensive therapy after onset of elevated blood pressure in patients with primary proteinuric kidney disease
publisher Elsevier
series Kidney Medicine
issn 2590-0595
publishDate 2020-03-01
description Rationale & Objective: The objective of the study was to estimate the prevalence of hypertension in patients with proteinuric kidney disease and evaluate blood pressure (BP) control. Study Design: Retrospective cohort study. Setting & Participants: Data from adults and children with proteinuric kidney disease enrolled in the multicenter Kidney Research Network Registry were used for this study. Exposure: Proteinuric kidney disease. Outcomes: Hypertension and BP control. Analytical Approach: Patients with white-coat hypertension were excluded. Patients were censored at end-stage kidney disease onset. Patients were defined as hypertensive either by hypertension diagnosis code, having 2 or more encounters with elevated BPs, or treatment with antihypertensive therapy excluding renin-angiotensin-aldosterone system blockade. Elevated BP was defined as greater than 95th percentile for children and >140/90 mm Hg in adults. Sustained BP control was defined as 2 or more consecutive encounters with BPs lower than 95th percentile for children and <140/90 mm Hg for adults. Kaplan-Meier and Cox proportional hazards analyses were used to evaluate the time to initiation of antihypertensive therapy. Results: 842 patients, 69% adults and 31% children, with a total observation period of 6,722 patient-years were included in the analysis. 644 (76%) had hypertension during observation. There was no difference in the prevalence of hypertension between children and adults (74% vs 78%; P = 0.3). Hypertension was most common among those of African American race compared with other races (90% vs 72%-75%; P = 0.003). 504 (78%) patients with hypertension achieved BP control but only 51% achieved control within 1 year. 140 (22%) patients with hypertension never achieved BP control during a median of 41 (IQR, 24-73) months of observation. Limitations: Differing BP control goals that may lead to overestimation of the controlled patient population. Conclusions: Hypertension affects most patients with proteinuric kidney disease regardless of age. Time to BP control exceeded 1 year in 50% of patients with hypertension and 22% did not demonstrate control. This study highlights the need to address hypertension early and completely in disease management of patients with proteinuric kidney disease. Index Words: Chronic kidney disease, elevated blood pressure, hypertension, proteinuria
url http://www.sciencedirect.com/science/article/pii/S2590059520300017
work_keys_str_mv AT donaldjweaverjr timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT annewaldo timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT giajoh timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT elaineskamil timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT matthewelliott timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT sharonadler timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT annepesenson timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT megmmodes timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT patrickgipson timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT richardalafayette timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT davidtselewski timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT samaraeattalla timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT richardeikstadt timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT jonathanptroost timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT debbiesgipson timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT susanfmassengill timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
_version_ 1724930294779215872
spelling doaj-899d8103430c4959aaf1e74a4511fe592020-11-25T02:07:41ZengElsevierKidney Medicine2590-05952020-03-0122131138Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney DiseaseDonald J. Weaver, Jr.0Anne Waldo1Gia J. Oh2Elaine S. Kamil3Matthew Elliott4Sharon Adler5Anne Pesenson6Meg M. Modes7Patrick Gipson8Richard A. Lafayette9David T. Selewski10Samara E. Attalla11Richard Eikstadt12Jonathan P. Troost13Debbie S. Gipson14Susan F. Massengill15Division of Pediatric Nephrology, Levine Children’s Hospital at Atrium Health, Charlotte, NCDivision of Nephrology, Department of Pediatrics & Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MIDivision of Nephrology, Department of Pediatrics, Stanford University, Stanford, CACedars-Sinai Medical Center, Los Angeles, CAMetrolina Nephrology Associates, Charlotte, NCLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, CAThe Polyclinic, Seattle, WAPatient Advocate, Livonia, MIDivision of Nephrology, Department of Pediatrics & Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI; Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, MIDivision of Nephrology and Hypertension, Stanford University, Stanford, CADivision of Nephrology, Department of Pediatrics & Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MIDivision of Nephrology, Department of Pediatrics & Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MIDivision of Nephrology, Department of Pediatrics & Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MIDivision of Nephrology, Department of Pediatrics & Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MIDivision of Nephrology, Department of Pediatrics & Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MIDivision of Pediatric Nephrology, Levine Children’s Hospital at Atrium Health, Charlotte, NC; Address for Correspondence: Susan F. Massengill, MD, Dept of Pediatrics, Levine Children’s Hospital at Atrium Health, 1001 Blythe Blvd, LCSC Ste C, Charlotte, NC 28203.Rationale & Objective: The objective of the study was to estimate the prevalence of hypertension in patients with proteinuric kidney disease and evaluate blood pressure (BP) control. Study Design: Retrospective cohort study. Setting & Participants: Data from adults and children with proteinuric kidney disease enrolled in the multicenter Kidney Research Network Registry were used for this study. Exposure: Proteinuric kidney disease. Outcomes: Hypertension and BP control. Analytical Approach: Patients with white-coat hypertension were excluded. Patients were censored at end-stage kidney disease onset. Patients were defined as hypertensive either by hypertension diagnosis code, having 2 or more encounters with elevated BPs, or treatment with antihypertensive therapy excluding renin-angiotensin-aldosterone system blockade. Elevated BP was defined as greater than 95th percentile for children and >140/90 mm Hg in adults. Sustained BP control was defined as 2 or more consecutive encounters with BPs lower than 95th percentile for children and <140/90 mm Hg for adults. Kaplan-Meier and Cox proportional hazards analyses were used to evaluate the time to initiation of antihypertensive therapy. Results: 842 patients, 69% adults and 31% children, with a total observation period of 6,722 patient-years were included in the analysis. 644 (76%) had hypertension during observation. There was no difference in the prevalence of hypertension between children and adults (74% vs 78%; P = 0.3). Hypertension was most common among those of African American race compared with other races (90% vs 72%-75%; P = 0.003). 504 (78%) patients with hypertension achieved BP control but only 51% achieved control within 1 year. 140 (22%) patients with hypertension never achieved BP control during a median of 41 (IQR, 24-73) months of observation. Limitations: Differing BP control goals that may lead to overestimation of the controlled patient population. Conclusions: Hypertension affects most patients with proteinuric kidney disease regardless of age. Time to BP control exceeded 1 year in 50% of patients with hypertension and 22% did not demonstrate control. This study highlights the need to address hypertension early and completely in disease management of patients with proteinuric kidney disease. Index Words: Chronic kidney disease, elevated blood pressure, hypertension, proteinuriahttp://www.sciencedirect.com/science/article/pii/S2590059520300017